Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | MMP2 | P08253 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL17335911 | 0.98 | ALDH1A1 (0.50) | ALDH1A1L3MBTL1MAPK1TAAR1HTT | |
| Hydrochloric Acid SCHEMBL31258271 | 0.97 | ALDH1A1 (0.49) | ALDH1A1L3MBTL1MAPK1TAAR1HTT | |
| SCHEMBL7303574 | 0.93 | LTA4H (0.52) | ALDH1A1L3MBTL1MAPK1TAAR1HTT | |
| SCHEMBL7301925 | 0.92 | MMP2 (0.52) | ALDH1A1L3MBTL1MAPK1TAAR1HTT | |
| SCHEMBL23518457 | 0.91 | ALDH1A1 (0.51) | ALDH1A1L3MBTL1MAPK1TAAR1HTT | |
| SCHEMBL20844332 | 0.87 | MAPT (0.51) | ALDH1A1L3MBTL1LMNAPOLBKMT2A | |
| SCHEMBL20334484 | 0.87 | HDAC3 (0.50) | ALDH1A1L3MBTL1MAPK1TAAR1HTT | |
| Hydrochloric Acid SCHEMBL23748118 | 0.86 | HDAC3 (0.49) | ALDH1A1L3MBTL1MAPK1TAAR1HTT | |
| SCHEMBL19733921 | 0.85 | ALDH1A1 (0.51) | ALDH1A1L3MBTL1MAPK1TAAR1HTT | |
| SCHEMBL19384905 | 0.85 | HTT (0.64) | L3MBTL1HTTMMP2LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3155436-B1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LTD (GB) | 2023-08-30 | — | — | EP | disclosed |
| EP-3155436-B1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LTD (GB) | 2023-08-30 | — | — | EP | disclosed |
| EP-3080608-B1 | MASS LABELS | ELECTROPHORETICS LTD (GB) | 2023-02-01 | — | — | EP | disclosed |
| US-10697976-B2 | Mass labels | ELECTROPHORETICS LIMITED (GB) | 2020-06-30 | — | — | US | disclosed |
| US-20170146549-A1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2017-05-25 | — | — | US | disclosed |
| US-20170146549-A1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2017-05-25 | — | — | US | disclosed |
| US-20170146549-A1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2017-05-25 | — | — | US | disclosed |
| EP-3155436-A1 | ISOBARIC MASS LABELS | Electrophoretics Limited (GB) | 2017-04-19 | — | — | EP | disclosed |
| US-20170045526-A1 | MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2017-02-16 | — | — | US | disclosed |
| US-9527964-B2 | Thermoplastic elastomers containing an oligopeptide hard component | THE UNIVERSITY OF AKRON (US) | 2016-12-27 | — | — | US | disclosed |
| WO-2015189413-A1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2015-12-17 | — | — | WO | disclosed |
| US-20150141574-A1 | THERMOPLASTIC ELASTOMERS CONTAINING AN OLIGOPEPTIDE HARD COMPONENT | THE UNIVERSITY OF AKRON (US) | 2015-05-21 | — | — | US | disclosed |
| EP-0445796-B1 | Derivatives of acetic acid containing peptide bonds | HOFFMANN LA ROCHE (CH) | 1998-06-17 | — | — | EP | disclosed |
| US-5430024-A | Peptides bearing N-terminal amidino moieties and their use as inhibitors of platelet aggregation | HOFFMANN-LA ROCHE INC. (US) | 1995-07-04 | — | — | US | disclosed |
| US-5273982-A | An amidinoaryleneamidoalkylpiperazinyleneacetic acid | HOFFMANN-LA ROCHE INC. (US) | 1993-12-28 | — | — | US | disclosed |
| EP-0445796-A2 | Derivatives of acetic acid | F. HOFFMANN-LA ROCHE AG (CH) | 1991-09-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170146549-A1 | ISOBARIC MASS LABELS | SRMS, PTMS, QPCTL | ALDH1A1 725/4885L3MBTL1 102/4885MAPK1 4548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.